UBP28_HUMAN - dbPTM
UBP28_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UBP28_HUMAN
UniProt AC Q96RU2
Protein Name Ubiquitin carboxyl-terminal hydrolase 28
Gene Name USP28
Organism Homo sapiens (Human).
Sequence Length 1077
Subcellular Localization Nucleus, nucleoplasm .
Protein Description Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells. [PubMed: 24623306]
Protein Sequence MTAELQQDDAAGAADGHGSSCQMLLNQLREITGIQDPSFLHEALKASNGDITQAVSLLTDERVKEPSQDTVATEPSEVEGSAANKEVLAKVIDLTHDNKDDLQAAIALSLLESPKIQADGRDLNRMHEATSAETKRSKRKRCEVWGENPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYRSKELIRNKRECIRKLKEEIKILQQKLERYVKYGSGPARFPLPDMLKYVIEFASTKPASESCPPESDTHMTLPLSSVHCSVSDQTSKESTSTESSSQDVESTFSSPEDSLPKSKPLTSSRSSMEMPSQPAPRTVTDEEINFVKTCLQRWRSEIEQDIQDLKTCIASTTQTIEQMYCDPLLRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKIPQMESSTNSSSQDYSTSQEPSVASSHGVRCLSSEHAVIVKEQTAQAIANTARAYEKSGVEAALSEVMLSPAMQGVILAIAKARQTFDRDGSEAGLIKAFHEEYSRLYQLAKETPTSHSDPRLQHVLVYFFQNEAPKRVVERTLLEQFADKNLSYDERSISIMKVAQAKLKEIGPDDMNMEEYKKWHEDYSLFRKVSVYLLTGLELYQKGKYQEALSYLVYAYQSNAALLMKGPRRGVKESVIALYRRKCLLELNAKAASLFETNDDHSVTEGINVMNELIIPCIHLIINNDISKDDLDAIEVMRNHWCSYLGQDIAENLQLCLGEFLPRLLDPSAEIIVLKEPPTIRPNSPYDLCSRFAAVMESIQGVSTVTVK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
38PhosphorylationITGIQDPSFLHEALK
HHCCCCHHHHHHHHH
49.0528555341
45UbiquitinationSFLHEALKASNGDIT
HHHHHHHHHCCCCHH
57.74-
64UbiquitinationLLTDERVKEPSQDTV
HHCCCCCCCCCCCCC
70.8621906983
64 (in isoform 1)Ubiquitination-70.8621890473
64 (in isoform 2)Ubiquitination-70.8621890473
67PhosphorylationDERVKEPSQDTVATE
CCCCCCCCCCCCCCC
41.6017525332
70PhosphorylationVKEPSQDTVATEPSE
CCCCCCCCCCCCHHH
12.3825159151
73PhosphorylationPSQDTVATEPSEVEG
CCCCCCCCCHHHCCC
44.0627732954
85UbiquitinationVEGSAANKEVLAKVI
CCCCHHCHHHHHHHH
44.46-
90UbiquitinationANKEVLAKVIDLTHD
HCHHHHHHHHHCCCC
35.25-
95PhosphorylationLAKVIDLTHDNKDDL
HHHHHHCCCCCHHHH
24.3628674419
99SumoylationIDLTHDNKDDLQAAI
HHCCCCCHHHHHHHH
59.6928112733
99SumoylationIDLTHDNKDDLQAAI
HHCCCCCHHHHHHHH
59.69-
109PhosphorylationLQAAIALSLLESPKI
HHHHHHHHHHHCCCC
23.1427080861
113PhosphorylationIALSLLESPKIQADG
HHHHHHHCCCCCCCC
31.3129496963
130PhosphorylationLNRMHEATSAETKRS
HHHHHHHCCHHHHHH
26.0325159151
131PhosphorylationNRMHEATSAETKRSK
HHHHHHCCHHHHHHH
31.0220068231
134PhosphorylationHEATSAETKRSKRKR
HHHCCHHHHHHHHHC
31.3229396449
220PhosphorylationMFMQELQYLFALMMG
HHHHHHHHHHHHHHC
19.1924043423
228PhosphorylationLFALMMGSNRKFVDP
HHHHHHCCCCCCCCH
18.6324043423
243 (in isoform 2)Ubiquitination-56.3321890473
243 (in isoform 1)Ubiquitination-56.3321890473
243UbiquitinationSAALDLLKGAFRSSE
HHHHHHHHHHHCCCH
56.3321890473
243UbiquitinationSAALDLLKGAFRSSE
HHHHHHHHHHHCCCH
56.3321890473
248PhosphorylationLLKGAFRSSEEQQQD
HHHHHHCCCHHHHHC
35.3329214152
249PhosphorylationLKGAFRSSEEQQQDV
HHHHHCCCHHHHHCH
40.6829214152
279PhosphorylationQLAVNVNSPRNKSEN
HHHHHCCCCCCCCCC
22.4327422710
375PhosphorylationSRFEFNQSLGQPEKI
EEHHCCHHCCCCHHH
35.2625159151
381UbiquitinationQSLGQPEKIHNKLEF
HHCCCCHHHHCCCCC
56.82-
420UbiquitinationRKLKEEIKILQQKLE
HHHHHHHHHHHHHHH
40.41-
425UbiquitinationEIKILQQKLERYVKY
HHHHHHHHHHHHHHH
39.08-
431UbiquitinationQKLERYVKYGSGPAR
HHHHHHHHHCCCCCC
34.65-
447PhosphorylationPLPDMLKYVIEFAST
CCCHHHHHHHHHHCC
11.60-
488PhosphorylationSDQTSKESTSTESSS
CCCCCCCCCCCCCCC
31.2420873877
489PhosphorylationDQTSKESTSTESSSQ
CCCCCCCCCCCCCCC
40.5420873877
490PhosphorylationQTSKESTSTESSSQD
CCCCCCCCCCCCCCC
39.1820873877
491PhosphorylationTSKESTSTESSSQDV
CCCCCCCCCCCCCCH
39.7220873877
493PhosphorylationKESTSTESSSQDVES
CCCCCCCCCCCCHHH
35.0625159151
494PhosphorylationESTSTESSSQDVEST
CCCCCCCCCCCHHHH
26.2820873877
495PhosphorylationSTSTESSSQDVESTF
CCCCCCCCCCHHHHC
39.4117478428
500PhosphorylationSSSQDVESTFSSPED
CCCCCHHHHCCCCCC
34.3020873877
501PhosphorylationSSQDVESTFSSPEDS
CCCCHHHHCCCCCCC
17.6520873877
503PhosphorylationQDVESTFSSPEDSLP
CCHHHHCCCCCCCCC
45.1025159151
504PhosphorylationDVESTFSSPEDSLPK
CHHHHCCCCCCCCCC
28.2828985074
508PhosphorylationTFSSPEDSLPKSKPL
HCCCCCCCCCCCCCC
44.9327251275
512PhosphorylationPEDSLPKSKPLTSSR
CCCCCCCCCCCCCCC
37.2524719451
513UbiquitinationEDSLPKSKPLTSSRS
CCCCCCCCCCCCCCC
50.61-
516PhosphorylationLPKSKPLTSSRSSME
CCCCCCCCCCCCCCC
32.9326330541
517PhosphorylationPKSKPLTSSRSSMEM
CCCCCCCCCCCCCCC
31.2825159151
518PhosphorylationKSKPLTSSRSSMEMP
CCCCCCCCCCCCCCC
30.8325627689
520PhosphorylationKPLTSSRSSMEMPSQ
CCCCCCCCCCCCCCC
35.6625159151
521PhosphorylationPLTSSRSSMEMPSQP
CCCCCCCCCCCCCCC
20.0425159151
542UbiquitinationDEEINFVKTCLQRWR
HHHHHHHHHHHHHHH
29.41-
543PhosphorylationEEINFVKTCLQRWRS
HHHHHHHHHHHHHHH
17.10-
550PhosphorylationTCLQRWRSEIEQDIQ
HHHHHHHHHHHHHHH
35.6525159151
654PhosphorylationYINDKLPYFNAEAAP
HHCCCCCCCCCCCCC
21.65-
708PhosphorylationCKIPQMESSTNSSSQ
CCCCCCCCCCCCCCC
36.8024043423
709PhosphorylationKIPQMESSTNSSSQD
CCCCCCCCCCCCCCC
20.5024043423
710PhosphorylationIPQMESSTNSSSQDY
CCCCCCCCCCCCCCC
48.6928348404
712PhosphorylationQMESSTNSSSQDYST
CCCCCCCCCCCCCCC
31.3029116813
713PhosphorylationMESSTNSSSQDYSTS
CCCCCCCCCCCCCCC
33.8029116813
714PhosphorylationESSTNSSSQDYSTSQ
CCCCCCCCCCCCCCC
27.2217525332
717PhosphorylationTNSSSQDYSTSQEPS
CCCCCCCCCCCCCCC
13.2524043423
718PhosphorylationNSSSQDYSTSQEPSV
CCCCCCCCCCCCCCH
29.8523312004
719PhosphorylationSSSQDYSTSQEPSVA
CCCCCCCCCCCCCHH
28.3523312004
720PhosphorylationSSQDYSTSQEPSVAS
CCCCCCCCCCCCHHH
26.9717478428
735PhosphorylationSHGVRCLSSEHAVIV
HCCCEECCCCCEEEE
36.9924719451
736PhosphorylationHGVRCLSSEHAVIVK
CCCEECCCCCEEEEE
22.0628348404
753PhosphorylationTAQAIANTARAYEKS
HHHHHHHHHHHHHHH
14.4321712546
788PhosphorylationAIAKARQTFDRDGSE
HHHHHHHHCCCCCCH
23.1923312004
794PhosphorylationQTFDRDGSEAGLIKA
HHCCCCCCHHHHHHH
28.6729970186
807 (in isoform 2)Ubiquitination-21.0621890473
839UbiquitinationFFQNEAPKRVVERTL
HHCCCCCHHHHHHHH
65.942190698
839 (in isoform 1)Ubiquitination-65.9421890473
853UbiquitinationLLEQFADKNLSYDER
HHHHHHCCCCCCCHH
57.25-
856PhosphorylationQFADKNLSYDERSIS
HHHCCCCCCCHHHHH
39.6722210691
857PhosphorylationFADKNLSYDERSISI
HHCCCCCCCHHHHHH
25.6222210691
861PhosphorylationNLSYDERSISIMKVA
CCCCCHHHHHHHHHH
20.7422210691
897UbiquitinationEDYSLFRKVSVYLLT
HHHHHHHHHHHHHHH
31.37-
901PhosphorylationLFRKVSVYLLTGLEL
HHHHHHHHHHHCHHH
6.6221955146
914PhosphorylationELYQKGKYQEALSYL
HHHHCCCHHHHHHHH
21.9129978859
919PhosphorylationGKYQEALSYLVYAYQ
CCHHHHHHHHHHHHH
24.3829978859
920PhosphorylationKYQEALSYLVYAYQS
CHHHHHHHHHHHHHC
10.8822210691
923PhosphorylationEALSYLVYAYQSNAA
HHHHHHHHHHHCCHH
9.3029978859
925PhosphorylationLSYLVYAYQSNAALL
HHHHHHHHHCCHHHH
8.5229978859
927PhosphorylationYLVYAYQSNAALLMK
HHHHHHHCCHHHHCC
18.7629978859
943PhosphorylationPRRGVKESVIALYRR
CCCCHHHHHHHHHHH
17.0723403867
948PhosphorylationKESVIALYRRKCLLE
HHHHHHHHHHHHHHH
10.1923403867
1037PhosphorylationLPRLLDPSAEIIVLK
HHHHHCCCCEEEEEC
37.8927080861
1048PhosphorylationIVLKEPPTIRPNSPY
EEECCCCCCCCCCHH
40.0924623306
1053PhosphorylationPPTIRPNSPYDLCSR
CCCCCCCCHHHHHHH
27.7623401153
1055PhosphorylationTIRPNSPYDLCSRFA
CCCCCCHHHHHHHHH
22.7422617229
1059PhosphorylationNSPYDLCSRFAAVME
CCHHHHHHHHHHHHH
37.4228450419
1067PhosphorylationRFAAVMESIQGVSTV
HHHHHHHHCCCCEEE
11.3420860994
1075PhosphorylationIQGVSTVTVK-----
CCCCEEEEEC-----
23.7520860994

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
67SPhosphorylationKinaseATMQ13315
PSP
495SPhosphorylationKinaseATMQ13315
PSP
714SPhosphorylationKinaseATMQ13315
PSP
720SPhosphorylationKinaseATMQ13315
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
67SPhosphorylation

16901786
714SPhosphorylation

16901786

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UBP28_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SUMO2_HUMANSUMO2physical
19615732
TP53B_HUMANTP53BP1physical
19615732
AQR_HUMANAQRphysical
19615732
TP53B_HUMANTP53BP1physical
16901786
CLSPN_HUMANCLSPNphysical
16901786
MDC1_HUMANMDC1physical
16901786
MYC_HUMANMYCphysical
17558397
FBXW7_HUMANFBXW7physical
17558397
UBP20_HUMANUSP20physical
22626734
UBP51_HUMANUSP51physical
22626734
UBP5_HUMANUSP5physical
22626734
UBP7_HUMANUSP7physical
22626734
STABP_HUMANSTAMBPphysical
22626734
OTUB1_HUMANOTUB1physical
22626734
JOS1_HUMANJOSD1physical
22626734
UCHL3_HUMANUCHL3physical
22626734
UBP8_HUMANUSP8physical
22626734
UCHL5_HUMANUCHL5physical
22626734
OTUB2_HUMANOTUB2physical
22626734
ATX3L_HUMANATXN3Lphysical
22626734
UBP33_HUMANUSP33physical
22626734
UBP15_HUMANUSP15physical
22626734
UBP28_HUMANUSP28physical
22626734
ESPL1_HUMANESPL1physical
22626734
SENP8_HUMANSENP8physical
22626734
UBP14_HUMANUSP14physical
22626734
STAM1_HUMANSTAMphysical
22626734
BAP1_HUMANBAP1physical
22626734
UCHL1_HUMANUCHL1physical
22626734
UBP21_HUMANUSP21physical
22626734
UBC_HUMANUBCphysical
22626734
UBP4_HUMANUSP4physical
22626734
ZC3H4_HUMANZC3H4physical
22939629
USO1_HUMANUSO1physical
22939629
ZCHC8_HUMANZCCHC8physical
22939629
MYC_HUMANMYCphysical
23389829
PA2GA_HUMANPLA2G2Aphysical
22118674
UBC_HUMANUBCphysical
25359778
KDM1A_HUMANKDM1Aphysical
24075993
MYC_HUMANMYCphysical
25716680
UBC_HUMANUBCphysical
26268556
SUMO2_HUMANSUMO2physical
26268556
ZN304_HUMANZNF304physical
24623306
KPCD1_HUMANPRKD1physical
24623306
UBC_HUMANUBCphysical
29131570

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UBP28_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.";
Zhang D., Zaugg K., Mak T.W., Elledge S.J.;
Cell 126:529-542(2006).
Cited for: FUNCTION, INTERACTION WITH TP53BP1, PHOSPHORYLATION AT SER-67 ANDSER-714, AND MUTAGENESIS OF CYS-171.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67 AND SER-714, AND MASSSPECTROMETRY.

TOP